Successful options exercise for Brain+

Copenhagen, October 2022 Brain+ has successfully completed the exercise window of their IPO warrants of TO1, with a subscription percentage of 82%, which is equivalent to DKK 6,4 million. The Company will thus receive DKK 6,4 million in capital before issuing costs. The Company is pleased with the exercise, which took place at DKK 1,638…

Successful options exercise for Spermosens

Lund, May 2022 Spermosens has successfully completed the exercise window of their IPO warrants of series TO 1, with a subscription percentage of 31%, totaling SEK 19,7 million in fresh capital to the Company. The Company is pleased with the exercise, which took place at SEK 12,29 per share, more than double the price of…

2021: Pre-IPO funding in numbers

December 2021: 4.6mDKK Pre-IPO funding for life-science company DK life-science company [name undisclosed] with unique platform technology closes a pre-IPO round, as a last step prior to an anticipated IPO in 2022. Gemstone acts as the Company’s financial advisor, and facilitated the process and transaction. June 2021: 10.2mDKK pre-IPO convertible loan for Brain+ Brain+ closes…

Brain+ lands partnership with Roche

Copenhagen, December 2021 Brain+ lands partnership with Roche for entry in Germany 2 years ahead of plan. “Brain+ has signed a partnership agreement with RoX Health (https://roxhealth.com/), a subsidiary of the global pharma company Roche in Germany, to bring its first dementia products to the German market.” Read more about the partnership HERE.   Brain+…

Expres2ion Biotechnologies announces positive results for its breast cancer vaccine

Copenhagen, December 2021 “ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) announces that its capsid virus-like particle (cVLP) breast cancer vaccine candidate ES2B-C001 demonstrated strong tumor-growth inhibiting effect in a mice model, thus reaching an important pre-clinical milestone ahead of schedule.” Read more about the exciting news HERE. Expres2ion was Gemstone Capital’s first IPO…